ArticleJournal of transport & health2021
Limiting mobility during COVID-19, when and to what level? An international comparative study using change point analysis.
Article in Journal of transport & health, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
24 citing papers in PubMed, 43 citations in OpenAlex.
- Spatial downscaling of multivariate disease risk.International journal of health geographics · 2026Article
- Multiple change point analysis and time series forecast of brucellosis reports in Xinjiang, China from 2010 to 2024.BMC public health · 2025Article
- Early detection of disease outbreaks and non-outbreaks using incidence data: A framework using feature-based time series classification and machine learning.PLoS computational biology · 2025Article
- Change point detection in brucellosis time series from 2010 to 2023 in Xinjiang China using the BEAST algorithm.Scientific reports · 2025Article
- Advance Monitoring of COVID-19 Incidence Based on Taxi Mobility: The Infection Ratio Measure.Healthcare (Basel, Switzerland) · 2024Article
- Cross-correlation and time series analysis of rabies in different animal species in Nepal from 2005 to 2018.Heliyon · 2024Article
- Replacing discontinued Big Tech mobility reports: a penetration-based analysis.Scientific reports · 2023Article
- Multiple change point analysis of hepatitis B reports in Xinjiang, China from 2006 to 2021.Frontiers in public health · 2023Article
- Impacts of COVID-19 on bike-sharing usages in Seoul, South Korea.Cities (London, England) · 2022Article
- Lumpy Skin Disease Outbreaks in Africa, Europe, and Asia (2005-2022): Multiple Change Point Analysis and Time Series Forecast.Viruses · 2022Article
- Explaining trip generation during the COVID-19 pandemic: A psychological perspective.Journal of transport & health · 2022Article
- Effects of tourism promotion on COVID-19 spread: The case of the "Go To Travel" campaign in Japan.Journal of transport & health · 2022Article
- PITS: An Intelligent Transportation System in pandemic times.Engineering applications of artificial intelligence · 2022Article
- Impact of pre-pandemic travel mobility patterns on the spatial diffusion of COVID-19 in South Korea.Journal of transport & health · 2022Article
- Data analytics during pandemics: a transportation and location planning perspective.Annals of operations research · 2022Article
- Analysis of the impact of non-compulsory measures on human mobility in Japan during the COVID-19 pandemic.Cities (London, England) · 2022Article
- Which factors influence mobility change during COVID-19 in Germany? Evidence from German county data.Regional science policy & practice · 2022Article
- The lockdown, mobility, and spatial health disparities in COVID-19 pandemic: A case study of New York City.Cities (London, England) · 2022Article
- Reassessment of contact restrictions and testing campaigns against COVID-19 via spatio-temporal modeling.Nonlinear dynamics · 2022Article
- Evaluating the impact of mobility in COVID-19 incidence and mortality: A case study from four states of Mexico.Frontiers in public health · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 2 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The year 2020 saw a rapid global spread of the highly contagious novel coronavirus COVID-19. To halt the spread of the disease, decision makers and governments across the world have been forced to limit mobility and human interaction, which led to a complete lockdown and the closure of nonessential businesses and public places in many cities and countries. Although effective in curbing the spread of the disease, such measures have had major social and economic impacts, particularly at locations where a complete lockdown was required. In such unprecedented circumstances, decision makers were faced with the dilemma of deciding on how and when to limit mobility to curb the spread of the disease, while being considerate of the significant economic impacts of enforcing such a lockdown. Limited research in this area meant that decision makers were forced to experiment different courses of action without fully understanding the consequences of those actions. To address this critical gap and to provide decision makers with more insights on how to manage mobility during a global pandemic, this paper conducts statistical change point analysis of mobility data from 10 different countries with the aims of establishing links between mobility trends, COVID-19 infections, and COVID-19 mortality rates across different countries where different policies were adopted. Among other findings, the analysis revealed that slow responders experienced significantly higher mortality rates per 100,000 people and were forced to implement stricter lockdown strategies when compared to early responders. The analysis also shows that operating at 40% level of mobility is achievable if appropriate action is taken early enough. The findings of this study are extremely valuable in helping nations better manage a, highly anticipated, second wave of COVID-19 or any other highly contagious global pandemic.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.